Cafepharma Today

May 22 2025 - Sanofi inks $470M Vigil buyout, brushing off rivals' failures to join Novartis in Alzheimer's race
Sanofi inks $470M Vigil buyout, brushing off rivals' failures to join Novartis in Alzheimer's race
FDA advisors unanimously snub Pfizer's Talzenna in broader prostate cancer population
Prices for new US drugs doubled in 4 years as focus on rare disease grows
FDA expands warnings of heart risks on COVID shots
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Is Biogen (BIIB) Poised to Beat Earnings Estimates?
Yahoo/Zacks.com
Tuesday, January 28, 2014 - 2:12pm
tags:
Biogen Idec, earnings
U.S. FDA panel: data support safety, efficacy of Merck allergy drug
Yahoo/Reuters
Tuesday, January 28, 2014 - 2:11pm
tags:
FDA, advisory panels, Merck, Ragwitek, ragweed pollen allergy
Forest Raises $1.8 Billion in Bond Sale to Fund Aptalis Takeover
Bloomberg/Businessweek
Tuesday, January 28, 2014 - 12:18pm
tags:
Forest, Aptalis, M&A, bonds
Intercept’s Fibrosis Success Gives Galectin High Hope
Wall St Cheat Sheet
Tuesday, January 28, 2014 - 12:17pm
tags:
Intercept Pharma, Galectin, Conatus Pharmaceuticals, OCA
Will the FDA Approve Vanda's Hetlioz?
Motley Fool
Tuesday, January 28, 2014 - 11:54am
tags:
Vanda, FDA, Hetlioz, non-24 hour disorder
Oramed's Data Will Define A New Standard For Diabetes
Seeking Alpha
Tuesday, January 28, 2014 - 11:52am
tags:
diabetes, Oramed Pharmaceuticals, ORMD-0801, oral insulin
Will Alexion's (ALXN) Earnings Streak End?
Yahoo/Zacks.com
Tuesday, January 28, 2014 - 11:50am
tags:
Alexion, earnings
GlaxoSmithKline plc And Its Drive For Growth
Motley Fool, UK
Tuesday, January 28, 2014 - 11:44am
tags:
GSK
Bayer’s Aleve May Have Lower Heart Risk Than Similar Pain Pills
Bloomberg
Tuesday, January 28, 2014 - 11:41am
tags:
Bayer, Aleve
For Meridian Bioscience, Living Up To The Past Could Prove Challenging
Seeking Alpha
Tuesday, January 28, 2014 - 11:39am
tags:
Meridian Bioscience, Illumigene
Analysis of FDA side-effect reports flags Sanofi, Celgene meds
Fierce Pharma
Tuesday, January 28, 2014 - 11:37am
tags:
Celegene, FDA, Sanofi, side effects, Pomalyst, Tecfidera, Biogen Idec, Aubagio
Cellceutix Is Significantly Undervalued Considering The Value Of Brilacidin
Seeking Alpha
Tuesday, January 28, 2014 - 11:19am
tags:
Cellceutix, Brilacidin, Kevetrin, Cubist Pharmaceuticals, Epizyme, Geron
Idenix Pharma CEO Speaks On Plans for the $107 Million Just Raised
TheStreet.com
Tuesday, January 28, 2014 - 11:17am
tags:
Idenix, Pharma CEOs, Gilead Sciences, hepatitis C, Ron Renaud
Aratana gets conditional approval for AT-005, a treatment for T-cell lymphoma in dogs
Yahoo/AP
Tuesday, January 28, 2014 - 11:16am
tags:
Aratana, AT-005, animal health
Will Celgene (CELG) Miss This Earnings Season?
Yahoo/Zacks.com
Tuesday, January 28, 2014 - 11:15am
tags:
Celgene, earnings
Neuralstem: Sizing Up Potential Key Events Of 2014
Seeking Alpha
Tuesday, January 28, 2014 - 11:09am
tags:
Neuralstem, NSI-189, NSI-566, stem cells
Will Recent Headlines Hurt Pfizer Stock?
Wall St Cheat Sheet
Tuesday, January 28, 2014 - 10:56am
tags:
Pfizer
OncoGenex Has A Potential Blockbuster Drug, But The Markets Are Pricing It Like An Orphan
Seeking Alpha
Tuesday, January 28, 2014 - 10:55am
tags:
OncoGenex, Isis Pharmaceuticals, Teva Pharmaceuticals, chemotherapy, OGX-011
3 Reasons to Focus on Diabetes
Motley Fool
Tuesday, January 28, 2014 - 10:53am
tags:
diabetes, AstraZeneca, Bristol-Myers Squibb, Xigduo, Pfizer
Bristol-Myers - Nivolumab's Delays Warrant Friday's Sell-Off
Seeking Alpha
Tuesday, January 28, 2014 - 8:50am
tags:
Bristol-Myers Squibb, nivolumab, AstraZeneca

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline
Lose Your Crystalline Form and Go Amorphous
In the Pipeline
Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.